Activated Notch1 Modulates Gene Expression in B Cells Similarly to Epstein-Barr Viral Nuclear Antigen 2
暂无分享,去创建一个
Georg W. Bornkamm | Markus Brielmeier | L. Strobl | U. Zimber-Strobl | M. Brielmeier | G. Bornkamm | Gabriele Marschall | Lothar J. Strobl | Heike Höfelmayr | Ursula Zimber-Strobl | H. Höfelmayr | G. Marschall
[1] T. Honjo,et al. Epstein‐Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP‐J kappa, the homologue of Drosophila Suppressor of Hairless. , 1994, The EMBO journal.
[2] D. Gutsch,et al. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus , 1991, Journal of virology.
[3] J. Hsieh,et al. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2 , 1996, Molecular and cellular biology.
[4] G. Struhl,et al. Intrinsic activity of the lin-12 and Notch intracellular domains in vivo , 1993, Cell.
[5] D. Rowe,et al. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes , 1992, Journal of virology.
[6] D. Fearon,et al. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[7] T. Honjo,et al. Purification and characterization of a protein that binds to the recombination signal sequence of the immunoglobulin Jx segment , 1989 .
[8] J. Banchereau,et al. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Pawlita,et al. Epstein‐Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c‐myc gene in Burkitt's lymphoma cells. , 1996, The EMBO journal.
[10] G. Lenoir,et al. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene , 1991, Journal of virology.
[11] A. Bigas,et al. Notch1 and Notch2 Inhibit Myeloid Differentiation in Response to Different Cytokines , 1998, Molecular and Cellular Biology.
[12] M. Fortini,et al. Notch: Neurogenesis is only part of the picture , 1993, Cell.
[13] U. Lendahl,et al. The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium , 1994, Mechanisms of Development.
[14] J. Rossant,et al. Conservation of the Notch signalling pathway in mammalian neurogenesis. , 1997, Development.
[15] P. Ling,et al. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. , 1994, Science.
[16] E. Kieff,et al. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] G. Weinmaster,et al. Notch2: a second mammalian Notch gene. , 1992, Development.
[18] L. Heston,et al. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye , 1982, Journal of virology.
[19] G. Weinmaster,et al. Notch1 is essential for postimplantation development in mice. , 1994, Genes & development.
[20] J. Knutson. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization , 1990, Journal of virology.
[21] E. Kieff,et al. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[22] K. Rajewsky,et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells , 1996, The Journal of experimental medicine.
[23] L. Strobl,et al. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa. , 1997, Immunobiology.
[24] Raphael Kopan,et al. An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells. , 1994, Development.
[25] B. Fowlkes,et al. Notch Activity Influences the αβ versus γδ T Cell Lineage Decision , 1997, Cell.
[26] E. Kieff,et al. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation , 1991, Journal of virology.
[27] H. Hermeking,et al. Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.
[28] P. Ling,et al. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Anderson,et al. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. , 1998, Immunity.
[30] M. Pawlita,et al. Improving stable transfection efficiency: antioxidants dramatically improve the outgrowth of clones under dominant marker selection. , 1998, Nucleic acids research.
[31] I. Bernstein,et al. Inhibition of granulocytic differentiation by mNotch1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] L. Strobl,et al. Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element , 1994, Journal of virology.
[33] E. Kieff,et al. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1 , 1990, Journal of virology.
[34] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.
[35] J. Strominger,et al. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[36] G. Weinmaster,et al. An Activated Form of Notch Influences the Choice between CD4 and CD8 T Cell Lineages , 1996, Cell.
[37] Kenji Matsuno,et al. Notch signaling. , 1995, Science.
[38] L. Young,et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells , 1993, The Journal of experimental medicine.
[39] G. Kelsoe,et al. Dependence of germinal center B cells on expression of CD21/CD35 for survival. , 1998, Science.
[40] K. Rajewsky,et al. In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.
[41] K. Rajewsky,et al. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] E. Kieff,et al. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[43] P. Simpson,et al. The choice of cell fate in the epidermis of Drosophila , 1991, Cell.
[44] G. Lenoir,et al. Expression of the Epstein-Barr virus (EBV) latent membrane protein is tightly regulated, independently of EB nuclear antigen 2 and of EBV integration or copy number. , 1993, Virus research.
[45] M. Bevan,et al. Correlating notch signaling with thymocyte maturation. , 1998, Immunity.
[46] B. Fowlkes,et al. Notch Activity Influences the a versus ?d T Cell Lineage Decision , 1997 .
[47] D. Gallahan,et al. Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells , 1992, Journal of virology.
[48] M. W. Young,et al. Antineurogenic phenotypes induced by truncated Notch proteins indicate a role in signal transduction and may point to a novel function for Notch in nuclei. , 1993, Genes & development.
[49] W. Hammerschmidt,et al. The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization. , 1996, The Journal of general virology.
[50] Raphael Kopan,et al. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain , 1998, Nature.
[51] G. Lenoir,et al. Aberrant c‐myc RNAs of Burkitt's lymphoma cells have longer half‐lives. , 1985, The EMBO journal.
[52] G. Struhl,et al. Nuclear Access and Action of Notch In Vivo , 1998, Cell.
[53] T. Honjo,et al. Purification and characterization of a protein that binds to the recombination signal sequence of the immunoglobulin J kappa segment. , 1989, Nucleic acids research.
[54] K. Takada. Cross‐linking of cell surface immunoglobulins induces epstein‐barr virus in burkitt lymphoma lines , 1984, International journal of cancer.
[55] E. Kieff. Epstein-Barr virus and its replication , 1996 .
[56] D. Thorley-Lawson,et al. EBV persistence in memory B cells in vivo. , 1998, Immunity.
[57] E. Kieff,et al. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1 , 1995, Journal of virology.
[58] T. Tedder,et al. CD20: a regulator of cell-cycle progression of B lymphocytes. , 1994, Immunology today.
[59] M. Pawlita,et al. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines. , 1996, The Journal of general virology.
[60] L. Strobl,et al. Activated Mouse Notch1 Transactivates Epstein-Barr Virus Nuclear Antigen 2-Regulated Viral Promoters , 1999, Journal of Virology.
[61] G. Weinmaster,et al. A homolog of Drosophila Notch expressed during mammalian development. , 1991, Development.
[62] J. Yates,et al. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus , 1985, Molecular and cellular biology.
[63] D. Fearon,et al. Complement: instructing the acquired immune system through the CD21/CD19 complex. , 1996, Research in immunology.
[64] J. Mcneil,et al. When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates , 1991, Journal of virology.
[65] J. Banchereau,et al. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23 , 1990, Journal of virology.
[66] F. Moreau-Gachelin,et al. The Spi‐1/PU.1 and Spi‐B ets family transcription factors and the recombination signal binding protein RBP‐J kappa interact with an Epstein‐Barr virus nuclear antigen 2 responsive cis‐element. , 1994, The EMBO journal.
[67] E. Kremmer,et al. The Epstein‐Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis‐element of the terminal protein 1 gene promoter. , 1993, The EMBO journal.
[68] T. Honjo,et al. A protein binding to the Jk recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif , 1989, Nature.
[69] P. Simpson,et al. The LIN-12/Notch signaling pathway and its regulation. , 1997, Annual review of cell and developmental biology.
[70] L. Waltzer,et al. The human J kappa recombination signal sequence binding protein (RBP‐J kappa) targets the Epstein‐Barr virus EBNA2 protein to its DNA responsive elements. , 1994, The EMBO journal.
[71] D. Eick,et al. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. , 1994, Oncogene.
[72] H. Weintraub,et al. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[73] M. W. Young,et al. Ligand-induced cleavage and regulation of nuclear entry of Notch in Drosophila melanogaster embryos. , 1998, Genes & development.
[74] E. Kieff,et al. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[75] H. Macdonald,et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. , 1999, Immunity.
[76] H. Weintraub,et al. The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. , 1994, Development.
[77] Bin Yang,et al. Identification of the Site of Epstein-Barr Virus Persistence In Vivo as a Resting B Cell , 1998, Journal of Virology.
[78] F. Schweisguth,et al. Indirect evidence for Delta-dependent intracellular processing of Notch in Drosophila embryos , 1998, Current Biology.
[79] E. Kieff,et al. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[80] G. Klein,et al. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus , 1990, Nature.
[81] E. Kieff,et al. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation , 1993, Journal of virology.
[82] I. Bernstein,et al. A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. , 1994, Blood.
[83] R. Issels,et al. Apoptosis in Burkitt lymphoma cells is prevented by promotion of cysteine uptake , 1998, International journal of cancer.
[84] J. Inman,et al. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2). , 1997, Journal of immunology.
[85] W. Hammerschmidt,et al. Genetic analysis of immortalizing functions of EpsteinBarr virus in human B lymphocytes , 1989, Nature.